introduced in the UK to accelerate population coverage with a single dose. In a study of 503
healthcare workers, we show that after priming following the first vaccine there is a marked
decline in SARS-CoV-2 neutralizing antibody (NAb) levels, but, in contrast, a sustained T
cell response to spike protein. This divergent immune profile was accompanied by robust
protection from infection over this period from the circulating alpha (B. 1.1. 7) variant …